Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
34.00
Aug 04 • 3:55 PM ET Dollar change+15.01 Percentage change(79.04%)
Aftermarket Close
30.67
Aftermarket • 4:15 PM ET Dollar change-3.33 Percentage change(-9.79%)
Today, 10:01 AMNasdaq debut post-Galera merger and $350M PIPE drives OBX 147% surge
Index
-
Market Cap
39.42M
Enterprise Value
33.92M
Income
149.03M
Sales
0.00M
Book/sh
13.29
Cash/sh
4.74
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
3
IPO
-
P/E
0.09
Forward P/E
-
PEG
-
P/S
-
P/B
2.56
P/C
7.17
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
5.31
Current Ratio
5.31
Debt/Eq
0.00
LT Debt/Eq
0.00
Option/Short
No / No
EPS (ttm)
396.88
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
- -
EPS Y/Y TTM
-
Sales Y/Y TTM
-
EPS Q/Q
-0.87%
Sales Q/Q
-
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
-
Insider Trans
-
Inst Own
-
Inst Trans
-
ROA
2156.02%
ROE
-
ROIC
2967.05%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
0.00%
SMA50
0.00%
SMA200
0.00%
Trades
Shs Outstand
-
Shs Float
0.49M
52W High
- -
52W Low
- -
Volatility
- -
ATR (14)
24.97
RSI (14)
-
Beta
-
Rel Volume
-
Avg Volume
-
Volume
12,616
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
Perf YTD
-
Perf Year
-
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Prev Close
18.99
Price
34.00
Change
79.04%
Galera Therapeutics, Inc. is a clinical stage biotechnology company, which engages in developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. It is also involved in the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis, and cancer. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.